I. Neuropathogenesis and Biomarkers
New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment
Neurocognitive Impairment and Associated Genetic Aspects in HIV Infection
Inflammatory Mechanisms and Cascades Contributing to Neurocognitive Impairment in HIV/AIDS
Neuroimaging Advances in Diagnosis and Differentiation of HIV, Comorbidities, and Aging in the cART Era
II. Neurocognitive Impairments in Low-, Middle- and High-Income Countries' Incidence / Prevalence and Contexts
Neurocognitive Complications of Pediatric HIV Infections
Neurocognitive Complications of HIV Infection in Women: Insights from the WIHS Cohort
Cultural Neuropsychology Considerations in the Diagnosis of HIV- Associated Neurocognitive Disorders
Neurocognitive Complications of HIV Infection in Low-Income Countries
Deep Phenotyping of HIV Neurocognitive Complications Among Individuals Residing in High-Income Countries
Reliably Measuring Cognitive Change in the Era of Chronic HIV Infection and Chronic HIV-Associated Neurocognitive Disorders
III. Comorbidities and Complications
Geriatric Syndromes in People Living with HIV Associated with Ageing and Increasing Comorbidities: Implications for Neurocognitive Complications of HIV Infection
Conceptualizing and Assessing Everyday Functioning in the Context of HIV-Associated Neurocognitive Disorders
Neuropsychiatric Disorders, Emotional Disturbances, and Their Associations with HIV-Associated Neurocognitive Disorder
Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders
HIV-Associated Neurocognitive Disorder (HAND): Relative Risk Factors
IV. Screening, Interventions and Clinical Management
Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity
Behavioral and Physical Activity Interventions for HAND
Targeting HIV-Related Neurocognitive Impairments with Cognitive Training Strategies: Insights from the Cognitive Aging Literature
Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and Adjuvants.